Art therapy for Parkinson's disease.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
03 2021
Historique:
received: 28 05 2020
revised: 01 12 2020
accepted: 14 01 2021
pubmed: 3 2 2021
medline: 28 12 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

To explore the potential rehabilitative effect of art therapy and its underlying mechanisms in Parkinson's disease (PD). Observational study of eighteen patients with PD, followed in a prospective, open-label, exploratory trial. Before and after twenty sessions of art therapy, PD patients were assessed with the UPDRS, Pegboard Test, Timed Up and Go Test (TUG), Beck Depression Inventory (BDI), Modified Fatigue Impact Scale and PROMIS-Self-Efficacy, Montreal Cognitive Assessment, Rey-Osterrieth Complex Figure Test (RCFT), Benton Visual Recognition Test (BVRT), Navon Test, Visual Search, and Stop Signal Task. Eye movements were recorded during the BVRT. Resting-state functional MRI (rs-fMRI) was also performed to assess functional connectivity (FC) changes within the dorsal attention (DAN), executive control (ECN), fronto-occipital (FOC), salience (SAL), primary and secondary visual (V1, V2) brain networks. We also tested fourteen age-matched healthy controls at baseline. At baseline, PD patients showed abnormal visual-cognitive functions and eye movements. Analyses of rs-fMRI showed increased functional connectivity within DAN and ECN in patients compared to controls. Following art therapy, performance improved on Navon test, eye tracking, and UPDRS scores. Rs-fMRI analysis revealed significantly increased FC levels in brain regions within V1 and V2 networks. Art therapy improves overall visual-cognitive skills and visual exploration strategies as well as general motor function in patients with PD. The changes in brain connectivity highlight a functional reorganization of visual networks.

Identifiants

pubmed: 33526323
pii: S1353-8020(21)00029-8
doi: 10.1016/j.parkreldis.2021.01.013
pii:
doi:

Types de publication

Clinical Trial Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-154

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Alberto Cucca (A)

The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NYU School of Medicine, New York, NY, USA; Department of Life Sciences, University of Trieste, Trieste, Italy; Department of Physical Medicine and Rehabilitation, Villa Margherita Fresco Parkinson Center, Vicenza, Italy. Electronic address: alberto.cucca@nyulangone.org.

Alessandro Di Rocco (A)

Department of Neurology, Zucker School of Medicine, Hofstra/Northwell Health, New York, NY, USA.

Ikuko Acosta (I)

Department of Art and Art Professions, NYU Steinhardt, New York, NY, USA.

Mahya Beheshti (M)

Department of Rehabilitation Medicine, NYU School of Medicine, New York, NY, USA.

Marygrace Berberian (M)

Department of Art and Art Professions, NYU Steinhardt, New York, NY, USA.

Hilary C Bertisch (HC)

Department of Rehabilitation Medicine, NYU School of Medicine, New York, NY, USA.

Amgad Droby (A)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Tom Ettinger (T)

Department of Art and Art Professions, NYU Steinhardt, New York, NY, USA.

Todd E Hudson (TE)

Department of Rehabilitation Medicine, NYU School of Medicine, New York, NY, USA.

Matilde Inglese (M)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Italy.

Yoon J Jung (YJ)

Department of Physiology and Pharmacology, City University of New York Medical School, New York, NY, USA.

Daniella F Mania (DF)

The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NYU School of Medicine, New York, NY, USA.

Angelo Quartarone (A)

Department of Biomedical, Dental Sciences and Morphological and Functional Images, University of Messina, Messina, Italy.

John-Ross Rizzo (JR)

Department of Rehabilitation Medicine, NYU School of Medicine, New York, NY, USA; Department of Neurology, NYU School of Medicine, New York, NY, USA; Biomedical Engineering, Mechanical & Aerospace Engineering, Tandon School of Engineering, Brooklyn, NY, USA.

Kush Sharma (K)

The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NYU School of Medicine, New York, NY, USA.

Andrew Feigin (A)

The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NYU School of Medicine, New York, NY, USA.

Milton C Biagioni (MC)

The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NYU School of Medicine, New York, NY, USA.

M Felice Ghilardi (MF)

Department of Physiology and Pharmacology, City University of New York Medical School, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH